AMPK modulates Hippo pathway activity to regulate energy homeostasis (original) (raw)

• Pan, D. The hippo signaling pathway in development and cancer. Dev. Cell 19, 491–505 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Zhao, B., Li, L., Lei, Q. & Guan, K. L. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev. 24, 862–874 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Halder, G. & Johnson, R. L. Hippo signaling: growth control and beyond. Development 138, 9–22 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Zhao, B., Li, L., Tumaneng, K., Wang, C. Y. & Guan, K. L. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF_β_−TRCP. Genes Dev. 24, 72–85 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Jiao, S. et al. A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer. Cancer Cell 25, 166–180 (2014).
  Article CAS PubMed Google Scholar
• Zhang, W. et al. VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex. Cell Res. 24, 331–343 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Lu, L. et al. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc. Natl Acad. Sci. USA 107, 1437–1442 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Cai, J. et al. The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev. 24, 2383–2388 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Lee, K. P. et al. The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc. Natl Acad. Sci. USA 107, 8248–8253 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Camargo, F. D. et al. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr. Biol. 17, 2054–2060 (2007).
  Article CAS PubMed Google Scholar
• Dong, J. et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130, 1120–1133 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Mo, J. S., Park, H. W. & Guan, K. L. The Hippo signaling pathway in stem cell biology and cancer. EMBO Rep. 15, 642–656 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Zhao, B. et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 21, 2747–2761 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Zhao, B. et al. Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev. 26, 54–68 (2012).
  Article PubMed PubMed Central Google Scholar
• Halder, G., Dupont, S. & Piccolo, S. Transduction of mechanical and cytoskeletal cues by YAP and TAZ. Nat. Rev. Mol. Cell Biol. 13, 591–600 (2012).
  Article CAS PubMed Google Scholar
• Dupont, S. et al. Role of YAP/TAZ in mechanotransduction. Nature 474, 179–183 (2011).
  Article CAS PubMed Google Scholar
• Yu, F. X. et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150, 780–791 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Jones, R. G. & Thompson, C. B. Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev. 23, 537–548 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Cairns, R. A., Harris, I. S. & Mak, T. W. Regulation of cancer cell metabolism. Nat. Rev. Cancer 11, 85–95 (2011).
  Article CAS PubMed Google Scholar
• Egan, D. F. et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331, 456–461 (2011).
  Article CAS PubMed Google Scholar
• Crute, B. E., Seefeld, K., Gamble, J., Kemp, B. E. & Witters, L. A. Functional domains of the alpha1 catalytic subunit of the AMP-activated protein kinase. J. Biol. Chem. 273, 35347–35354 (1998).
  Article CAS PubMed Google Scholar
• Hao, Y., Chun, A., Cheung, K., Rashidi, B. & Yang, X. Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J. Biol. Chem. 283, 5496–5509 (2008).
  Article CAS PubMed Google Scholar
• Fujishiro, S. H. et al. ERK1/2 phosphorylate GEF-H1 to enhance its guanine nucleotide exchange activity toward RhoA. Biochem. Biophys. Res. Commun. 368, 162–167 (2008).
  Article CAS PubMed Google Scholar
• Wu, S. Z. et al. Akt and RhoA activation in response to high glucose require caveolin-1 phosphorylation in mesangial cells. Am. J. Physiol. Renal Physiol. 306, F1308–F1317 (2014).
  Article CAS PubMed Google Scholar
• Zhang, Y., Peng, F., Gao, B., Ingram, A. J. & Krepinsky, J. C. High glucose-induced RhoA activation requires caveolae and PKCbeta1-mediated ROS generation. Am. J. Physiol. Renal Physiol. 302, F159–F172 (2012).
  Article CAS PubMed Google Scholar
• Zhao, B. et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 22, 1962–1971 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Stubbs, M., McSheehy, P. M., Griffiths, J. R. & Bashford, C. L. Causes and consequences of tumour acidity and implications for treatment. Mol. Med. Today 6, 15–19 (2000).
  Article CAS PubMed Google Scholar
• Zhang, H., Pasolli, H. A. & Fuchs, E. Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin. Proc. Natl Acad. Sci. USA 108, 2270–2275 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Yamamoto, T. et al. Over-expression of facilitative glucose transporter genes in human cancer. Biochem. Biophys. Res. Commun. 170, 223–230 (1990).
  Article CAS PubMed Google Scholar
• Mellanen, P., Minn, H., Grenman, R. & Harkonen, P. Expression of glucose transporters in head-and-neck tumors. Int. J. Cancer 56, 622–629 (1994).
  Article CAS PubMed Google Scholar
• Boado, R. J., Black, K. L. & Pardridge, W. M. Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors. Brain Res. Mol. Brain Res. 27, 51–57 (1994).
  Article CAS PubMed Google Scholar
• Younes, M., Brown, R. W., Stephenson, M., Gondo, M. & Cagle, P. T. Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival. Cancer 80, 1046–1051 (1997).
  Article CAS PubMed Google Scholar
• Ayala, F. R. et al. GLUT1 and GLUT3 as potential prognostic markers for oral squamous cell carcinoma. Molecules 15, 2374–2387 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Ha, T. K. & Chi, S. G. CAV1/caveolin 1 enhances aerobic glycolysis in colon cancer cells via activation of SLC2A3/GLUT3 transcription. Autophagy 8, 1684–1685 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Mo, J-S. et al. Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway. Nat. Cell Biol. 17, http://dx.doi.org/10.1038/ncb3111 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• DeRan, M. et al. Energy stress regulates Hippo-YAP signaling involving AMPK-mediated regulation of angiomotin-like 1 protein. Cell Rep. 9, 495–503 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Shevchenko, A., Wilm, M., Vorm, O. & Mann, M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68, 850–858 (1996).
  Article CAS PubMed Google Scholar
• Peng, J. & Gygi, S. P. Proteomics: the move to mixtures. J. Mass Spectrom. 36, 1083–1091 (2001).
  Article CAS PubMed Google Scholar
• Eng, J. K., McCormack, A. L. & Yates, J. R. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 5, 976–989 (1994).
  Article CAS PubMed Google Scholar
• Beausoleil, S. A., Villen, J., Gerber, S. A., Rush, J. & Gygi, S. P. A probability-based approach for high-throughput protein phosphorylation analysis and site localization. Nat. Biotechnol. 24, 1285–1292 (2006).
  Article CAS PubMed Google Scholar